Picture of Adial Pharmaceuticals logo

ADIL — Adial Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Adial Pharmaceuticals Inc - On August 31, Received Written Notice From Nasdaq Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard

Sept 2 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS INC -  ON AUGUST 31, RECEIVED
WRITTEN
NOTICE FROM NASDAQ OF DELISTING OR FAILURE TO SATISFY A
CONTINUED LISTING RULE OR STANDARD

Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Adial Pharmaceuticals

See all news